Simon G. Goller

Josef Schneider Str. 2
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

sQUIZ your knowledge! Refractory erythroderma with a wood-grain pattern.

sQUIZ your knowledge! Refractory erythroderma with a wood-grain pattern.

Journal: European journal of dermatology : EJD

Published: July 27, 2026

sQUIZ your knowledge! Sudden eruption of haemorrhagic crusts in a young patient.

sQUIZ your knowledge! Sudden eruption of haemorrhagic crusts in a young patient.

Journal: European journal of dermatology : EJD

Published: July 27, 2026

Rapid regression of a mucosal melanoma after a single dose of immune checkpoint inhibitors.

Rapid regression of a mucosal melanoma after a single dose of immune checkpoint inhibitors.

Journal: European journal of dermatology : EJD

Published: May 25, 2026

Journal Club: Cutaneous mosaicism: clinical patterns, genetic mechanisms, and practical implications for the dermatologist.

Journal Club: Cutaneous mosaicism: clinical patterns, genetic mechanisms, and practical implications for the dermatologist.

Journal: European journal of dermatology : EJD

Published: May 25, 2026

Early Detection of Melanoma

Early Detection of Melanoma

Journal: MMW Fortschritte der Medizin

Published: May 12, 2026

Journal Club: Current state of neoadjuvant therapy for melanoma.

Journal Club: Current state of neoadjuvant therapy for melanoma.

Journal: European journal of dermatology : EJD

Published: March 23, 2026

AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanoma.

AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanoma.

Journal: Neoplasia (New York, N.Y.)

Published: February 17, 2026

Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies.

Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies.

Journal: European journal of dermatology : EJD

Published: January 29, 2026

Immune checkpoint inhibitor-induced bullous pemphigoid effectively controlled by dupilumab.

Immune checkpoint inhibitor-induced bullous pemphigoid effectively controlled by dupilumab.

Journal: European journal of dermatology : EJD

Published: January 29, 2026

Journal Club. Genetic pathways in melanoma: molecular foundations and clinical implications.

Journal Club. Genetic pathways in melanoma: molecular foundations and clinical implications.

Journal: European journal of dermatology : EJD

Published: November 24, 2025

Mogamulizumab-associated rash and lymphocytopenia coinciding with treatment response of Sézary syndrome.

Mogamulizumab-associated rash and lymphocytopenia coinciding with treatment response of Sézary syndrome.

Journal: European journal of dermatology : EJD

Published: September 18, 2025

Journal club: Dupilumab and remibrutinib as treatment for chronic spontaneous urticaria: new pathways in disease control.

Journal club: Dupilumab and remibrutinib as treatment for chronic spontaneous urticaria: new pathways in disease control.

Journal: European journal of dermatology : EJD

Published: September 18, 2025

Showing 1-12 of 20

Last Updated: 09/26/2026